BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30175246)

  • 41. Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial.
    Ker K; Kiriya J; Perel P; Edwards P; Shakur H; Roberts I
    BMC Emerg Med; 2012 Mar; 12():3. PubMed ID: 22380715
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Effect of Tranexamic Acid on Functional Outcomes: An Exploratory Analysis of the CRASH-2 Randomized Controlled Trial.
    Nishijima DK; Kuppermann N; Roberts I; VanBuren JM; Tancredi DJ
    Ann Emerg Med; 2019 Jul; 74(1):79-87. PubMed ID: 30642657
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and tolerance of early administration of tranexamic acid in patients with cirrhosis presenting with acute upper gastrointestinal bleeding: a study protocol for a multicentre, randomised, double-blind, placebo-controlled trial (the EXARHOSE study).
    Heidet M; Amathieu R; Audureau E; Augusto O; Nicolazo de Barmon V; Rialland A; Schmitz D; Pierrang F; Marty J; Chollet-Xémard C; Thirion O; Jacob L
    BMJ Open; 2018 Aug; 8(8):e021943. PubMed ID: 30099397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients.
    Gayet-Ageron A; Prieto-Merino D; Ker K; Shakur H; Ageron FX; Roberts I;
    Lancet; 2018 Jan; 391(10116):125-132. PubMed ID: 29126600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Traumatic injury clinical trial evaluating tranexamic acid in children (TIC-TOC): study protocol for a pilot randomized controlled trial.
    Nishijima DK; VanBuren J; Hewes HA; Myers SR; Stanley RM; Adelson PD; Barnhard SE; Bobinski M; Ghetti S; Holmes JF; Roberts I; Schalick WO; Tran NK; Tzimenatos LS; Michael Dean J; Kuppermann N;
    Trials; 2018 Oct; 19(1):593. PubMed ID: 30376893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous Tranexamic Acid for Brain Contusion with Intraparenchymal Hemorrhage: Randomized, Double-Blind, Placebo-Controlled Trial.
    Mousavinejad M; Mozafari J; Ilkhchi RB; Hanafi MG; Ebrahimi P
    Rev Recent Clin Trials; 2020; 15(1):70-75. PubMed ID: 31744452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms.
    Roberts I; Edwards P; Prieto D; Joshi M; Mahmood A; Ker K; Shakur H
    Trials; 2017 Jan; 18(1):48. PubMed ID: 28143564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tranexamic Acid During Prehospital Transport in Patients at Risk for Hemorrhage After Injury: A Double-blind, Placebo-Controlled, Randomized Clinical Trial.
    Guyette FX; Brown JB; Zenati MS; Early-Young BJ; Adams PW; Eastridge BJ; Nirula R; Vercruysse GA; O'Keeffe T; Joseph B; Alarcon LH; Callaway CW; Zuckerbraun BS; Neal MD; Forsythe RM; Rosengart MR; Billiar TR; Yealy DM; Peitzman AB; Sperry JL;
    JAMA Surg; 2020 Oct; 156(1):11-20. PubMed ID: 33016996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antifibrinolytic drugs for acute traumatic injury.
    Roberts I; Shakur H; Ker K; Coats T;
    Cochrane Database Syst Rev; 2012; 12():CD004896. PubMed ID: 23418644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of tranexamic acid on the prognosis of patients with traumatic brain injury undergoing craniotomy: study protocol for a randomised controlled trial.
    Wu B; Lu Y; Yu Y; Yue H; Wang J; Chong Y; Cui W
    BMJ Open; 2021 Nov; 11(11):e049839. PubMed ID: 34824110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of tranexamic acid in traumatic brain injury: A randomized controlled trial.
    Jokar A; Ahmadi K; Salehi T; Sharif-Alhoseini M; Rahimi-Movaghar V
    Chin J Traumatol; 2017 Feb; 20(1):49-51. PubMed ID: 28209450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial.
    Meretoja A; Yassi N; Wu TY; Churilov L; Sibolt G; Jeng JS; Kleinig T; Spratt NJ; Thijs V; Wijeratne T; Cho DY; Shah D; Cloud GC; Phan T; Bladin C; Moey A; Aviv RI; Barras CD; Sharma G; Hsu CY; Ma H; Campbell BCV; Mitchell P; Yan B; Parsons MW; Tiainen M; Curtze S; Strbian D; Tang SC; Harvey J; Levi C; Donnan GA; Davis SM
    Lancet Neurol; 2020 Dec; 19(12):980-987. PubMed ID: 33128912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tranexamic acid is safe to use following mild-to-moderate traumatic brain injury.
    Cook R; Lyon-Maris J; Martin R;
    BMJ; 2020 Mar; 368():m514. PubMed ID: 32161036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association Between Prehospital Tranexamic Acid Administration and Outcomes of Severe Traumatic Brain Injury.
    Bossers SM; Loer SA; Bloemers FW; Den Hartog D; Van Lieshout EMM; Hoogerwerf N; van der Naalt J; Absalom AR; Peerdeman SM; Schwarte LA; Boer C; Schober P;
    JAMA Neurol; 2021 Mar; 78(3):338-345. PubMed ID: 33284310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protocol for a multicentre prehospital randomised controlled trial investigating tranexamic acid in severe trauma: the PATCH-Trauma trial.
    Mitra B; Bernard S; Gantner D; Burns B; Reade MC; Murray L; Trapani T; Pitt V; McArthur C; Forbes A; Maegele M; Gruen RL; ;
    BMJ Open; 2021 Mar; 11(3):e046522. PubMed ID: 33722875
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mortality and Complication Rates in Adult Trauma Patients Receiving Tranexamic Acid: A Single-center Experience in the Post-CRASH-2 Era.
    Erramouspe PJ; García-Pintos MF; Benipal S; Manoukian MAC; Santamarina JL; Shawagga HG; Vo LL; Galante JM; Nishijima D
    Acad Emerg Med; 2020 May; 27(5):358-365. PubMed ID: 32189440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Right median nerve electrical stimulation for acute traumatic coma (the Asia Coma Electrical Stimulation trial): study protocol for a randomised controlled trial.
    Wu X; Zhang C; Feng J; Mao Q; Gao G; Jiang J
    Trials; 2017 Jul; 18(1):311. PubMed ID: 28693604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial.
    Bouthors AS; Hennart B; Jeanpierre E; Baptiste AS; Saidi I; Simon E; Lannoy D; Duhamel A; Allorge D; Susen S
    Trials; 2018 Mar; 19(1):148. PubMed ID: 29490682
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial.
    Crescenti A; Borghi G; Bignami E; Bertarelli G; Landoni G; Casiraghi GM; Briganti A; Montorsi F; Rigatti P; Zangrillo A
    BMJ; 2011 Oct; 343():d5701. PubMed ID: 22012809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tranexamic acid for spontaneous intracerebral hemorrhage: a randomized controlled pilot trial (ISRCTN50867461).
    Sprigg N; Renton CJ; Dineen RA; Kwong Y; Bath PM
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1312-8. PubMed ID: 24680087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.